Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Sep 12, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Sep 12, 2003
Director, Ch, Pres. and Chief Exec. Off.
Director, Ch, Pres. and Chief Exec. Off. Grant, award or other acquisition pursuant to Rule 16b-3(d) 215,000 --
Sep 12, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Sep 05, 2003
Other
Other Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --
Sep 05, 2003
Director, Ch, Pres. and Chief Exec. Off.
Director, Ch, Pres. and Chief Exec. Off. Grant, award or other acquisition pursuant to Rule 16b-3(d) 225,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.